Skip to main content
. Author manuscript; available in PMC: 2017 Dec 20.
Published in final edited form as: Med Res Arch. 2017 Mar 15;5(3):10.18103/mra.v5i3.1084. doi: 10.18103/mra.v5i3.1084

Table 1.

Demographics of SLE Patients treated with Cyclophosphamide

Variables N (%)
Age (Years)
 n 31
 Mean 37.9
 STD 8.6
Ethnicity
 African American 8 (25.8%)
 Asian 2 (6.4%)
 Caucasian 6 (19.4%)
 Hispanic 15 (48.4%)
Sex
 Female 27 (87.1%)
 Male 4 (12.9%)
**

Total 42 courses of cyclophosphamide in 31 patients; denominator used is 42.